CD274 and neoplasm: PD-L1 has a high predictive value of immunotherapy response rate (Fig. 4b); the higher the PD-L1 expression (i.e., PD-L1 expression in > 50% of tumor cells) the better chance the patient will respond to immunotherapy [72, 73].